Status:
UNKNOWN
Cognitive Behavioral Therapy for University Students Diagnosed With Attention-deficit Hyperactivity Disorder (ADHD)
Lead Sponsor:
University of Iceland
Conditions:
Attention-deficit Hyperactivity
Eligibility:
All Genders
Phase:
NA
Brief Summary
Drug treatment is often the first and only line of treatment available for ADHD. However, some do not benefit from medication. The importance of psychotherapy is becoming more widely accepted. In this...
Detailed Description
A treatment manual for adults with ADHD was written based on the CBT model described in Young and Bramham's Handbook on ADHD in Adults (2007), Greenberger and Padesky's Mind Over Mood (2016) and Honos...
Eligibility Criteria
Inclusion
- University students who have previously been diagnosed with ADHD, and are fluent in Icelandic. Students with co-morbid disorders such as dyslexia, anxiety or depression will be included. Students currently receiving other psychological or medical treatment will be included.
Exclusion
- Students with psychotic disorders, autism spectrum disorders or drug dependence will be excluded.
Key Trial Info
Start Date :
October 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT04714866
Start Date
October 11 2018
End Date
December 31 2024
Last Update
May 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iceland
Reykjavik, Sæmundargata 2, Iceland, 102